The Commission has not received representatives from the United Kingdom government or health agencies on the implications of a no-deal Brexit for the medicines/medical equipment sector.

The Commission services have met relevant European trade associations and individual companies on a number of occasions to discuss the consequences of the United Kingdom withdrawal from the European Union.

The Commission’s consistent message has been that all companies must prepare for all withdrawal scenarios as a matter of urgency, on the basis of the extensive guidance provided by the Commission and the European Medicines Agency(1).

As regards the supply of medicines and medical equipment, of which emergency and trauma equipment are part, the Commission together with the European Medicines Agency and national regulators prepared Questions & Answers documents and information notices, and organised stakeholders meetings to ensure that the sector is prepared for all withdrawal scenarios.

The Commission provided an overview, which is publically available, of the latest state of play in the medicines/medical equipment sector in a preparedness seminar with Member States on 12 December 2018(2).

(1) Commission and European Medicines Agency websites with further information: https://www.ema.europa.eu/en/about-us/united-kingdoms-withdrawal-european-union-brexit https://ec.europa.eu/info/brexit/brexit-preparedness/preparedness-notices_en#sante https://ec.europa.eu/info/sites/info/files/file_import/industrial_products_en_1.pdf (2) https://ec.europa.eu/info/council-working-party-article-50-preparedness-seminars_en#growsanteenv-12122018